What Commission Implementing Decision (EU) 2016/109 of 27 January 2016 not to approve PHMB (1600; 1.8) as an existing active substance for use in biocidal products for product-types 1, 6 and 9 (Text with EEA relevance) requires
Commission Implementing Decision (EU) 2016/109, adopted at Brussels on 27 January 2016 by the European Commission under authority of Regulation (EU) No 528/2012 concerning the making available on the market and use of biocidal products…
This is a preview. The full record adds the complete summary, 12 workflow steps, 10 schema fields and 9 primary citations. Start a free trial or see pricing.
Pillar: Legal & IP Sovereignty · Authority: European Commission · Version: 1.0.0 · Last updated:
Primary source: https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32016D0109
SHA-256 integrity: 4f93abcb36b1d67a86dc12cfdf37119d897567dc3db04262d7444e7726ce18e7
Primary Citations — 9 traced to source
- Article 1: 'PHMB (1600; 1.8) (EC No: n.a., CAS No 27083-27-8 and 32289-58-0) is not approved as an active substance for use in biocidal products for product-types 1, 6 and 9.'
- Article 2: 'This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.'
+ 7 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/eu-celex-32016d0109.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/eu-celex-32016d0109.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/eu-celex-32016d0109
- Back to registry: Browse all 10,084 compliance nodes